- Home
- AACT vs AVNS Comparison
AACT vs AVNS Comparison
Compare AACT & AVNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AACT
- AVNS
- Stock Information
- Founded
- AACT 2021
- AVNS 2014
- Country
- AACT United States
- AVNS United States
- Employees
- AACT N/A
- AVNS N/A
- Industry
- AACT
- AVNS Industrial Specialties
- Sector
- AACT
- AVNS Health Care
- Exchange
- AACT Nasdaq
- AVNS Nasdaq
- Market Cap
- AACT 696.9M
- AVNS 641.7M
- IPO Year
- AACT 2023
- AVNS N/A
- Fundamental
- Price
- AACT $11.16
- AVNS $14.39
- Analyst Decision
- AACT
- AVNS Hold
- Analyst Count
- AACT 0
- AVNS 1
- Target Price
- AACT N/A
- AVNS N/A
- AVG Volume (30 Days)
- AACT 942.5K
- AVNS 517.1K
- Earning Date
- AACT 01-01-0001
- AVNS 05-01-2025
- Dividend Yield
- AACT N/A
- AVNS N/A
- EPS Growth
- AACT 15.24
- AVNS N/A
- EPS
- AACT 0.42
- AVNS N/A
- Revenue
- AACT N/A
- AVNS $687,800,000.00
- Revenue This Year
- AACT N/A
- AVNS $2.70
- Revenue Next Year
- AACT N/A
- AVNS $0.69
- P/E Ratio
- AACT $26.87
- AVNS N/A
- Revenue Growth
- AACT N/A
- AVNS 2.15
- 52 Week Low
- AACT $10.56
- AVNS $13.87
- 52 Week High
- AACT $11.20
- AVNS $25.36
- Technical
- Relative Strength Index (RSI)
- AACT 61.15
- AVNS 39.68
- Support Level
- AACT $11.14
- AVNS $14.10
- Resistance Level
- AACT $11.19
- AVNS $14.96
- Average True Range (ATR)
- AACT 0.03
- AVNS 0.39
- MACD
- AACT -0.00
- AVNS 0.01
- Stochastic Oscillator
- AACT 42.86
- AVNS 41.89
About AACT Ares Acquisition Corporation II
Ares Acquisition Corp II is a blank check company.
About AVNS Avanos Medical Inc.
Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. The company has now changed two franchises: has combined Chronic Care and Pain Management franchises into a single commercial organization focused on the Digestive Health and Pain Management and Recovery product categories that generate its revenue from its Chronic Care franchise and in North America.